PolarCath Peripheral Dilatation System— 510(k) K152665

Substantially Equivalent

Nucyro Vascular, LLC

FDA 510(k) clearance K152665 for PolarCath Peripheral Dilatation System, Substantially Equivalent on 2015-10-26. Applicant: Nucyro Vascular, LLC. Device class: 2.

Clearance details

Applicant
Nucyro Vascular, LLC
Product code
Code LIT
Device class
Class 2
Regulation
21 CFR 870.1250
Advisory panel
Cardiovascular
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Sunnyvale, CA, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code LIT

view all

Adverse events under product code LIT

product code LIT
Death
27
Injury
1,256
Malfunction
12,127
Total
13,410

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Recalls naming K152665

K-number listed on FDA's recall record

Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K152665.

Data sourced from openFDA. This site is unofficial and independent of the FDA.